Related references
Note: Only part of the references are listed.Elevated Epstein-Barr Virus-Encoded Nuclear Antigen-1 Immune Responses Predict Conversion to Multiple Sclerosis
Jan D. Luenemann et al.
ANNALS OF NEUROLOGY (2010)
TLR9 Contributes to the Recognition of EBV by Primary Monocytes and Plasmacytoid Dendritic Cells
Stephanie Fiola et al.
JOURNAL OF IMMUNOLOGY (2010)
Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI
R. A. Farrell et al.
NEUROLOGY (2009)
EBV in MS: guilty by association?
Jan D. Luenemann et al.
TRENDS IN IMMUNOLOGY (2009)
The IRF family transcription factors in immunity and oncogenesis
Tomohiko Tamura et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2
Jan D. Luenemann et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis
Jan D. Luenemann et al.
JOURNAL OF IMMUNOLOGY (2008)
Human plasmacytoid dendritic cells regulate immune responses to Epstein-Barr virus (EBV) infection and delay EBV-related mortality in humanized NOD-SCID mice
Wai Hon Lim et al.
BLOOD (2007)
Environmental risk factors for multiple sclerosis. Part I: The role of infection
Alberto Ascherio et al.
ANNALS OF NEUROLOGY (2007)
Increased frequency and broadened specificity of latent EBV nuclear antigen-I-specific T cells in multiple sclerosis
Jan D. Lunemann et al.
BRAIN (2006)
Infectious mononucleosis and risk for multiple sclerosis: A meta-analysis
EL Thacker et al.
ANNALS OF NEUROLOGY (2006)
Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients
J Río et al.
ANNALS OF NEUROLOGY (2006)
Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis
LI Levin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo
D Hochberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays
JR Currier et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2002)
Epstein-Barr virus antibodies and risk of multiple sclerosis -: A prospective study
A Ascherio et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1
LW Zhang et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
